These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33529581)

  • 41. Conversion of a regulatory into a degradative protease.
    Hasenbein S; Meltzer M; Hauske P; Kaiser M; Huber R; Clausen T; Ehrmann M
    J Mol Biol; 2010 Apr; 397(4):957-66. PubMed ID: 20184896
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systematic screening of soluble expression of antibody fragments in the cytoplasm of E. coli.
    Gaciarz A; Veijola J; Uchida Y; Saaranen MJ; Wang C; Hörkkö S; Ruddock LW
    Microb Cell Fact; 2016 Jan; 15():22. PubMed ID: 26809624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional role of a non-active site residue Trp(23) on the enzyme activity of Escherichia coli thioesterase I/protease I/lysophospholipase L(1).
    Lee LC; Chou YL; Chen HH; Lee YL; Shaw JF
    Biochim Biophys Acta; 2009 Oct; 1794(10):1467-73. PubMed ID: 19540368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Display of Recombinant Proteins on Bacterial Outer Membrane Vesicles by Using Protein Ligation.
    van den Berg van Saparoea HB; Houben D; de Jonge MI; Jong WSP; Luirink J
    Appl Environ Microbiol; 2018 Apr; 84(8):. PubMed ID: 29439988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibody engineering.
    Dall'Acqua W; Carter P
    Curr Opin Struct Biol; 1998 Aug; 8(4):443-50. PubMed ID: 9729735
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SpyMask enables combinatorial assembly of bispecific binders.
    Driscoll CL; Keeble AH; Howarth MR
    Nat Commun; 2024 Mar; 15(1):2403. PubMed ID: 38493197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthetic Modular Antibody Construction by Using the SpyTag/SpyCatcher Protein-Ligase System.
    Alam MK; Gonzalez C; Hill W; El-Sayed A; Fonge H; Barreto K; Geyer CR
    Chembiochem; 2017 Nov; 18(22):2217-2221. PubMed ID: 28891272
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of SpyTag/SpyCatcher to construct bispecific antibodies that target two epitopes of a single antigen.
    Yumura K; Akiba H; Nagatoishi S; Kusano-Arai O; Iwanari H; Hamakubo T; Tsumoto K
    J Biochem; 2017 Sep; 162(3):203-210. PubMed ID: 28637250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improvements in the cell-free production of functional antibodies using cell extract from protease-deficient Escherichia coli mutant.
    Ali M; Suzuki H; Fukuba T; Jiang X; Nakano H; Yamane T
    J Biosci Bioeng; 2005 Feb; 99(2):181-6. PubMed ID: 16233776
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Binders from the deepest vaults.
    Carter P
    Nat Biotechnol; 1996 Mar; 14(3):267. PubMed ID: 9630883
    [No Abstract]   [Full Text] [Related]  

  • 51. Power to the protein: enhancing and combining activities using the Spy toolbox.
    Keeble AH; Howarth M
    Chem Sci; 2020 Jul; 11(28):7281-7291. PubMed ID: 33552459
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selection of recombinant antibodies from antibody gene libraries.
    Hust M; Dübel S; Schirrmann T
    Methods Mol Biol; 2007; 408():243-55. PubMed ID: 18314587
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Controlling macromolecular topology with genetically encoded SpyTag-SpyCatcher chemistry.
    Zhang WB; Sun F; Tirrell DA; Arnold FH
    J Am Chem Soc; 2013 Sep; 135(37):13988-97. PubMed ID: 23964715
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The periplasmic Escherichia coli peptidylprolyl cis,trans-isomerase FkpA. I. Increased functional expression of antibody fragments with and without cis-prolines.
    Bothmann H; Pluckthun A
    J Biol Chem; 2000 Jun; 275(22):17100-5. PubMed ID: 10748200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficient construction of a diabody using a refolding system: anti-carcinoembryonic antigen recombinant antibody fragment.
    Asano R; Kudo T; Nishimura Y; Makabe K; Hayashi H; Suzuki M; Tsumoto K; Kumagai I
    J Biochem; 2002 Dec; 132(6):903-9. PubMed ID: 12473192
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibody fragments: hope and hype.
    Nelson AL
    MAbs; 2010; 2(1):77-83. PubMed ID: 20093855
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selection and rapid purification of murine antibody fragments that bind a transition-state analog by phage display.
    McCafferty J; Fitzgerald KJ; Earnshaw J; Chiswell DJ; Link J; Smith R; Kenten J
    Appl Biochem Biotechnol; 1994; 47(2-3):157-71; discussion 171-3. PubMed ID: 7944335
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of a compact anti-BAFF antibody in Escherichia coli.
    Cao P; Zhang S; Gong Z; Tang X; Cao M; Hu Y
    Appl Microbiol Biotechnol; 2006 Nov; 73(1):151-7. PubMed ID: 16625393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selection of phage displayed antibodies based on kinetic constants.
    Dueñas M; Malmborg AC; Casalvilla R; Ohlin M; Borrebaeck CA
    Mol Immunol; 1996 Feb; 33(3):279-85. PubMed ID: 8649449
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the efficiency of antibody selection from semi-synthetic scFv and non-immune Fab phage display libraries against protein targets for rapid development of diagnostic immunoassays.
    Chan CE; Chan AH; Lim AP; Hanson BJ
    J Immunol Methods; 2011 Oct; 373(1-2):79-88. PubMed ID: 21856306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.